AXS / BitcoinLong
Axie Infinity Daily Chart Analysis
Yesterday we looked at Axie Infinity (AXSBTC) on the weekly/long-term chart... Today we will have a look at the daily timeframe.
First, we can see how nicely EMA50 and EMA100 match the Fibonacci numbers.
We have the highest volume bar since November 2021 and a break above EMA50 yesterday and EMA100 today.
Bullish indicators, MACD and RSI.
Now, my reason to post this is to show you the next target.
The main resistance short-term for this bullish move is the 1.618 Fib. extension level at 0.002061.
It is possible to have a correction or small retrace after this level is reached and then another jump to 2.618 Fib. which is sitting at 0.002633.
If you are trading this daily, you now have a better view of what is going to happen next.
I hope you enjoyed this analysis.
Thanks a lot for the continued support.
I Love You! :D
Namaste.
First, we can see how nicely EMA50 and EMA100 match the Fibonacci numbers.
We have the highest volume bar since November 2021 and a break above EMA50 yesterday and EMA100 today.
Bullish indicators, MACD and RSI.
Now, my reason to post this is to show you the next target.
The main resistance short-term for this bullish move is the 1.618 Fib. extension level at 0.002061.
It is possible to have a correction or small retrace after this level is reached and then another jump to 2.618 Fib. which is sitting at 0.002633.
If you are trading this daily, you now have a better view of what is going to happen next.
I hope you enjoyed this analysis.
Thanks a lot for the continued support.
I Love You! :D
Namaste.
🔥 PREMIUM Trade-Numbers
lamatrades.com (Since 2017)
🏆 Results: t.me/alansantana1111/5935
🥇XRP +1950 🥇ADA +2216% 🥇AVA +536% 🥇AAVE +417%
t.me/alansantanatrades/971
🔝 Cryptocurrency Technical Analysis
followalan.com
lamatrades.com (Since 2017)
🏆 Results: t.me/alansantana1111/5935
🥇XRP +1950 🥇ADA +2216% 🥇AVA +536% 🥇AAVE +417%
t.me/alansantanatrades/971
🔝 Cryptocurrency Technical Analysis
followalan.com
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.